Loading…
Xsensio has developed Lab-on-Skin™, a miniaturized wearable sensing platform for continuous, real-time biochemical monitoring (e.g., inflammation) to enable earlier detection of clinical deterioration. The technology targets ICU to home settings, with an initial product focused on early detection of organ dysfunction in critical care, oncology, and post-surgical recovery. Built on a semiconductor-based sensing chip from EPFL, Lab-on-Skin opens access to previously unexplored biochemical data, supported by IP and clinical collaborations.
AI named Xsensio from January 2026 to March 2026.